Evidence map›Paper›PMID 36907194›Full record

ReviewThe Lancet. Child & adolescent health2023

Non-pharmacological interventions for attention-deficit hyperactivity disorder in children and adolescents.

Margaret H Sibley, Alisha M Bruton, Xin Zhao, Jeanette M Johnstone, John Mitchell, Irene Hatsu, L Eugene Arnold, Hana H Basu, Laura Levy, Pooja Vyas and 8 more

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in The Lancet. Child & adolescent health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 8 pooled it
17.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 8 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 1 country.

Margaret H SibleyDepartment of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle Children's Research Institute, Seattle, WA, USA. Electronic address: margaret.sibley@seattlechildrens.org.
Alisha M BrutonDepartment of Psychiatry, Oregon Health Sciences University, Portland, OR, USA.
Xin ZhaoDepartment of Medicine, University of California-Irvine, Irvine, CA, USA.
Jeanette M JohnstoneDepartment of Psychiatry, Oregon Health Sciences University, Portland, OR, USA.
John MitchellDepartment of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA.
Irene HatsuDepartment of Human Sciences, Ohio State University, Columbus, OH, USA.
L Eugene ArnoldDepartment of Psychiatry and Behavioral Health, Ohio State University, Columbus, OH, USA.
Hana H BasuDepartment of Psychology, University of Washington, Seattle, WA, USA.
Laura LevyDepartment of Medicine, Oregon Health Sciences University, Portland, OR, USA.
Pooja VyasDepartment of Medicine, Oregon Health Sciences University, Portland, OR, USA.
Fiona MacpheeDivision of Psychiatry and Behavioral Medicine, Seattle Children's Hospital, Seattle, WA, USA.
Erin Schoenfelder GonzalezDepartment of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle Children's Research Institute, Seattle, WA, USA.
Megan KelleyDepartment of Psychology, University of Washington, Seattle, WA, USA.
Morgan L JuskoDepartment of Psychology, Florida International University, Miami, FL, USA.
China R BoldenDivision of Psychiatry and Behavioral Medicine, Seattle Children's Hospital, Seattle, WA, USA.
Courtney Zulauf-McCurdyDepartment of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle Children's Research Institute, Seattle, WA, USA.
Maychelle ManzanoDepartment of Psychology, University of Washington, Seattle, WA, USA.
Gabriela TorresDepartment of Psychology, Florida International University, Miami, FL, USA.
University of Washington · USOregon Health & Science University · USSeattle Children's Hospital · USFlorida International University · USThe Ohio State University · USDuke University · USUniversity of California, Irvine · US

Funding

CAM Research Training in Neuroscience &StressT32AT002688 · NCCIH · OREGON HEALTH & SCIENCE UNIVERSITY · PI OKEN, BARRY S, SOUMYANATH, AMALA · 2005 to 2025
$7.2M
Optimizing Research Methodology in a Multinutrient Study of Racially and Ethnically Diverse Children with ADHD and Emotional DysregulationK23AT012068 · NCCIH · OREGON HEALTH & SCIENCE UNIVERSITY · PI JOHNSTONE, JEANETTE M · 2022 to 2025
$700k
NCCIH NIH HHS K23 AT012068NCCIH NIH HHS T32 AT002688
6 · The paper itself

Abstract

Attention-deficit hyperactivity disorder (ADHD) affects approximately 5% of children and adolescents globally and is associated with negative life outcomes and socioeconomic costs. First-generation ADHD treatments were predominantly pharmacological; however, increased understanding of biological, psychological, and environmental factors contributing to ADHD has expanded non-pharmacological treatment possibilities. This Review provides an updated evaluation of the efficacy and safety of non-pharmacological treatments for paediatric ADHD, discussing the quality and level of evidence for nine intervention categories. Unlike medication, no non-pharmacological treatments showed a consistent strong effect on ADHD symptoms. When considering broad outcomes (eg, impairment, caregiver stress, and behavioural improvement), multicomponent (cognitive) behaviour therapy joined medication as a primary ADHD treatment. With respect to secondary treatments, polyunsaturated fatty acids showed a consistent modest effect on ADHD symptoms when taken for at least 3 months. Additionally, mindfulness and multinutrient supplementation with four or more ingredients showed modest efficacy on non-symptom outcomes. All other non-pharmacological treatments were safe; clinicians might tolerate their use but should educate families of childrenand adolescents with ADHD on the disadvantages, including costs, burden to the service user, absence of proven efficacy relative to other treatments, and delay of proven treatment.

Indexed as

Attention Deficit Disorder with HyperactivityCognitive Behavioral TherapyAdolescentChildHumans

Identifiers

PMID36907194
PMCPMC10370370
OpenAlexW4323657263

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.